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Childhood Asthma
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Asthma prevalence in children has increased 58% since 1980. Mortality has increased by 78%.
The burden of the disease is most acute in urban areas and racial/ethnic minority populations.
Hospitalization and morbidity rates for nonwhites are more than twice those for whites. Asthma
is characterized by recurrent wheezing, breathlessness, chest tightness, and coughing. Research
in the past decade has revealed the importance of inflammation of the airways in asthma and
clinical treatment to reduce chronic inflammation. Asthma is associated with production of IgE to
common environmental allergens including house dust mite, animal dander, cockroach, fungal
spores, and pollens. Some interventions to reduce symptoms through control of dust mite and
animal dander have had positive results. Control of symptoms through interventions to reduce
exposures to cockroach antigen has not been reported. Studies illustrating causal effects
between outdoor air pollution and asthma prevalence are scant. Increases in asthma prevalence
have occurred at the same time as general improvements in air quality. However, air quality
appears to exacerbate symptoms in the child who already has the disease. Decreased pulmonary
function has been associated with exposure to particulates and bronchial hyperresponsiveness to
smoke, SO2 and NO2. Symptoms have been correlated with increased levels of respirable
particulates, ozone, and SO2. Interventions that reduce the negative outcomes in asthma
associated with outdoor environmental factors have not been reported. Control of asthma in
children will entail the collaborative efforts of patients, family, clinical professionals, and school
personnel, as well as community-wide environmental control measures and conducive national
and local policies based on sound research. Key words: asthma control, child health, childhood
asthma, environmental precipitants. - Environ Health Perspect 107(suppl 31:421429 (1999).
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Prevalence, Diagnosis,
Treatment, and Precipitants
ofAsthma
Prevalence ofAsthmain Children
In the past 20 years significant increases in
pediatric asthma have been noted in this
country and worldwide. Asthma is the most
common chronic disease of childhood in
the developed world, affecting approxi-
mately 10 million children in the United
States under 16 years of age (1). Between
1982 and 1992, the prevalence rate for
pediatric asthma (under 18 years ofage) in
the United States increased by 58%. The
mortality rate from asthma for persons 19
years of age and under increased by 78%
from 1980 to 1993.
Activity limitation and the use ofhealth
services for asthma are significant. In 1994
there were 169,000 hospital discharges for
the disease among children under 15 years
of age, a rate ofalmost 30 per 10,000 pop-
ulation. Statistics for 1996 show that
although asthma was the 10th most com-
mon principal diagnosis in emergency
department visits among all patients,
asthma led in emergency department visits
for children, excluding accidents (2). In
1995 there were 9 million physician office
visits for asthma in the United States and a
significant number of these represented
pediatric visits. The proportion ofpeople
with asthma who have ictivity limitation
rose fromjust over 19% in 1988 to 22% in
1994. Again, children accounted for a sig-
nificant portion ofthis limited activity (2).
The costs associated with health care use
and disability attributed to asthma are high.
Direct medical expenditures for all patients
with asthma amounted to $3.64 billion
in 1990, and indirect economic losses
accounted for an additional $2.6 billion
(2). These indirect costs include such fac-
tors as days missed from work or school,
caregiver expenditures, travel and waiting
time, and premature mortality.
Asthma is.particularly troublesome in
urban populations (1) and racial/ethnic
minority populations (3). In the United
States, the asthma hospitalization and mor-
bidity rates for nonwhites are more than
twice those for whites. The activity limita-
tion rate is higher in African Americans;
about 30% ofAfrican Americans with
asthma have restricted activity because of
their disease. The causes ofincreased mor-
bidity and the differential riJ for urban,
racial/ethnic minority populations are not
well understood (4). It is hypothesized that
increased rates are likely due to multiple
factors such as high levels ofexposure to
environmental pollutants including tobacco
smoke and environmental allergens, lack of
access to medical care, and lack offinancial
resources and social support to manage the
disease effectively on along-term basis (2).
There are also costs ofasthma related to
the social and psychological domains of
childhood. Data suggest that children's
school absences and school performance are
affected by the disease (5,6), although
greaterabsenteeism than the general popula-
tion has not been demonstrated (7). Some
observers have noted that psychological
adjustment (e.g., self-esteem) ofchildren
with asthma is inferior to children without
the disease (5,6), but this opinion has
received limited empirical study and is ques-
tioned (8). There is little doubt that the
condition often restricts recreation, play,
and related forms ofphysical activity and its
management can be a source ofcontention
and disruptionwithin families (9).
TheDiagnosis ofAsthma
Asthma is defined as "a chronic inflamma-
tory disorder ofthe airways in which many
cells and cellular elements play a role...in
susceptible individuals, this inflammation
causes recurrent episodes ofwheezing,
breathlessness, chest tightness, andcoughing,
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particularly at night or in the early morn-
ing. These episodes are usually associated
with widespread but variable airflow
obstruction that is often reversible either
spontaneously or with treatment. The
inflammation also causes an associated
increase in the existing bronchial hyperre-
sponsiveness to a variety ofstimuli" (10).
Asthma usually begins in childhood, often
in association with an inherited susceptibil-
ity to produce IgE to common environ-
mental allergens, including house dust
mite, animal protein, fungal spores, and
pollens (11). It is estimated that up to 80%
ofchildren with asthma may be atopic. A
range of other precipitants, discussed
below, is associated with symptoms of
asthma. The key indicators for considering
a diagnosis of asthma are a history of
cough, particularly if it worsens at night;
recurrent wheezing; recurrent difficulty in
breathing; or recurrent chest tightness (12).
Although asthma cannot be cured, it can be
controlled by a combination ofpharmaco-
logic and nonpharmacologic means.
Accurate diagnosis ofasthma is complex,
and it is believed that the disease continues
to be underdiagnosed and undertreated
(13). In recognition of this fact, the
National Asthma Education and Prevention
Program (NAEPP) was established by the
National Institutes ofHealth in 1989 to
enable professionals, patients, and com-
munities to manage the condition more
effectively. The expert panel guidelines
promulgated by the NAEPP (10) have
become the basis for clinical practice in
the United States and an adaptation pro-
vided by an international working group
(Global Initiative on Asthma) serves as the
basis for clinical practice outside the
United States (14).
AsthmaTreatment
Paradoxically, although asthma prevalence
has reached alarmingly high rates over
recent years, therapies for pharmacologic
treatment of asthma have also advanced
dramatically. Important in enhancing
treatment has been the recognition of the
central role ofinflammation in the disease.
Continuous use ofanti-inflammatory med-
icine to combat this underlying factor and
use of bronchodilators to reduce constric-
tion ofthe bronchial tubes during exacer-
bations are considered to be the frontline
treatment for the disease for patients over
5 years ofagewith persistent symptoms.
The number ofpatients who actually
receive anti-inflammatory prescriptions
from their physicians is thought to be small
compared to what is indicated. In low-
income communities this gap between the
need for and use ofanti-inflammatory med-
icine is even greater. For example, a recently
conducted study of 597 children with
asthma in grades 2-5, attending 15 schools
in Detroit, Michigan, classified their disease
severity according to NAEPP expert panel
guidelines (10). Just over 20% ofchildren
with both moderate persistent and severe
persistent asthma were receiving anti-
inflammatory therapy. Guidelines would
suggest that virtually all of these children
should be on controller medicine. Recent
efforts by the NAEPP and professional soci-
eties ofclinicians have focused on increas-
ing practitioners' use ofanti-inflammatory
medicine for patients with asthma.
Causes ofAsthmaSymptoms
Two factors appear to predominate in
contributing to asthma episodes: colds
and viral respiratory infections. Asthma is
associated with perennial and seasonal
rhinitis and sinusitis (10), and research has
shown that the resulting inflammation
of the upper airway influences lower air-
way hyperresponsiveness and symptoms
(15-17). Another important contributing
factor to asthma symptoms is exercise. A
number of patients will only experience
asthma symptoms when physically active.
For others, exercise as well as other precipi-
tants may induce symptoms. Food and
food additives (e.g., sulfites), certain drugs
(e.g., aspirin), perfumes, or strong odors
are precipitants for some patients. There is
also evidence to suggest that changes in the
social and physical environment of a child
such as moving to a new home, going on
vacation, or alterations in work or study
space can precipitate asthma symptoms
(10). How much and how these changes
function to produce a physiologic response
is not clear.
Allergy has a significant role in the
pathophysiology ofasthma. Studies from
the United States, Europe, Australia, and
New Zealand have established that IgE-
mediated sensitization to indoor allergens
(dust mite, cockroach, cat, dog) is a major
risk factor for asthma and asthma exacerba-
tion (18-24). Because persistent exposure
to allergens and irritants (e.g., tobacco
smoke) induces airway inflammation and
hyperreactivity, environmental control is
viewed as a therapy to reduce or prevent
asthma symptoms (25). For purposes of
discussion, it is useful to categorize environ-
mental precipitants ofasthma symptoms as
those related to the physical environment
(indoor and outdoor) and social environ-
ment, although interactions of factors in
each categoryoccur.
Precipitants asthma symptoms in
the indoorphysical environment. DUST
MITE. Studies of the effects of dust mite
allergen presence in asthma are numerous.
House dust mites are found in the dust of
all homes built in temperate climates (26).
In addition to being a major precipitant of
attacks in children sensitive to the allergen,
there is evidence that exposure to dust mite
allergen, particularly in infants, may be an
important factor in inducing the onset of
asthma itself(18). The degree ofsymptom
response to dust mite in sensitive children
correlates with the extent of exposure
(21). The primary sources of dust mites
are beds, carpets, stuffed animals, uphol-
stered furniture, and other soft furnish-
ings. The usual approaches recommended
for control are encasing mattresses with a
covering impermeable to mite allergen,
washing bedding in very hot water (over
55°C) and removing offending materials.
These approaches significantly reduce
asthma exacerbations (27). Studies ofaca-
ricide effectiveness in mite control have
produced varying results (28,29), and the
long-term success ofusing different media
(benzyl benzoate, tannic acid) has been
questioned. Dust mites are more prevalent
in humid environments. Reducing mites
by controlling indoor humidity is believed
to be an effective means of control (10)
and has been shown to have a positive
effect on asthma symptoms (30).
COCKROACH. Up to 60% of children
with asthma test positive to cockroach aller-
gen (31). According to the NAEPP (10),
cockroach allergen is the most common
source of positive skin test reactions in
inner-city populations. The expert panel
guidelines recommend control through use
ofbaits and traps to avoid irritating odors
associated with chemical extermination,
which itselfmayproduce asthmasymptoms.
A factor complicating control is that cock-
roach allergen may be present when there is
no visible sign ofinfestation (32). To date,
there are no conclusive data to linkinterven-
tions to control cockroach antigens to
improvements in asthmasymptoms (27).
ANIMAL DANDER. For some children,
exposure to animal dander can cause symp-
toms ofasthma. Dander can be found par-
ticularly in carpeting and upholstery
exposed to the animal (33). Studies
(33,34) have shown that animal allergens
are transported on smaller particles than
those that carry house dust mite allergen.
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This means that dander allergens are likely
to remain suspended in the air for an
extended time, whereas mite allergen stays
in the air only a few minutes. Air filtration
systems may help with removal ofairborne
particles such as animal dander and
tobacco smoke. However, they are not
believed to be effective for allergens associ-
ated with heavy particles that rapidly fall
out ofthe air, such as dust mite and cock-
roach allergens (10). Removal of the ani-
mal source has been associated with
improvements in asthma symptoms but as
a practical measure is often difficult to
achieve (27).
TOBACCO SMOKE. Exposure to tobacco
smoke is accepted as an important contrib-
utor to asthma prevalence and worsens
asthma severity in both children and adults
(10). It is associated with more frequent
symptom exacerbations and increases in
emergency department visits (35). The
sole mode ofcontrol is to avoid inhaling
environmental tobacco smoke.
For most patients, control ofthe envi-
ronment is very difficult to achieve. Not all
measures will be effective in reduction of
asthma symptoms for a given child, as
responsiveness to particular precipitants is
highly individualistic. Some common activ-
ities thought to be remedial, such as vacu-
uming with a standard vacuum cleaner, can
produce an increase in allergen-containing
particles in the air and produce symptoms
in children with specific allergic reactions.
Further, general strategies for air quality
control are questionable in terms ofeffec-
tiveness of reducing symptoms, such as
maintaining clean heating, ventilation,
and air conditioning ducts. These mea-
sures will not affect house dust mite aller-
gen and no studies have demonstrated as
yet their effect on reduction of animal
dander. In short, control of indoor envi-
ronmental precipitants depends on the
type ofallergen in question.
There are other potential contributors
to asthma exacerbations related to home
and building construction. Tight housing
providing little ventilation, and use of
offensive building materials that emit
volatile organic chemicals (VOCs) and
formaldehyde have been discussed as influ-
ential in triggering asthma symptoms;
these speculations, however, have not been
empirically demonstrated.
Precipitants ofasthma symptoms in
the outdoor environment. Studies illustrat-
ing a causal effect between outdoor air pol-
lution and prevalence ofasthma are scant
and, in fact, the increase in the prevalence
of the disease in developed countries over
the last two decades has occurred at the
same time as general improvements in out-
door air quality (21). On the other hand,
studies have illustrated the deleterious
effect ofair pollution on patients who have
active symptoms of disease. For example,
decreased pulmonary function has been
associated with exposure to particulates
(36), and increases in bronchial hyperre-
sponsiveness with exposure to smoke, SO2,
and NO2 (37-39).
Increased ambient air pollution levels,
particularly ofrespirable particulates (40),
ozone (41), and SO2 (42) reportedly pre-
cipitate asthma symptoms. With respect to
particulate effects, studies in the United
States and Europe report an association
between increased morbidity and mortality
and ambient particulate matter (PM) con-
centrations at PM levels currently below
the U.S. National Ambient Air Quality
Standards (43,44). It is believed that fine
fraction particulate matter (< 2.5 pm)
(PM2.5) may be responsible for cardiopul-
monary effects observed (45). Exposure to
PM and co-pollutants in the ambient envi-
ronment also has been posed as an explana-
tion for increased morbidity and mortality
in urban centers (46). Together, these
studies suggest that air pollution is a com-
plex mixture that likely produces effects
that are important to the control of
asthma. For example, in studies ofthe tem-
poral relationship between air pollution
and acute illness leading to mortality or
hospital admissions, the relative risks asso-
ciated with realistic increases in air pollu-
tion levels are small (47). Nonetheless, the
number ofpeople affected in a large popu-
lation studied over a long period of time
can be significant, and some groups (e.g.,
the elderly and children with asthma) may
be particularly vulnerable.
Making the picture more complex is
the possibility that levels ofsome outdoor
air pollutants may influence indoor con-
centrations ofparticulate pollutants (26).
One study (48) showed a significant asso-
ciation between indoor particulate matter
and levels of outdoor particulates from
traffic emissions. To add to the problem,
the relative clinical importance ofindivid-
ual and combined elements of air quality
to asthma has not been demonstrated.
Such demonstration will not be easy, as
research separating the impact ofone form
ofpollutant from other forms in the air is
difficult to conduct (49,50).
Sensitivity to fungus and mold is of
concern in asthma. The outdoor fungus
Alternaria has been identified as a risk
factor for developing the disease in child-
hood (51). Mold allergy seems to be more
significant in children with asthma,
depending on their geographic location
(52), and has been implicated in severe
and life-threatening asthma exacerbations
(53,54). Being sensitive to outdoor pollens
carries less risk for asthma (55), although
grass and ragweed pollen exposure has been
associated with the disease (56).
Control in the case ofoutdoor precipi-
tants is usually in the form ofrecommend-
ing that patients curtail exercising during
days of high atmospheric pollution, as
increased respiration will increase the
amount of exposure. Remaining indoors
may decrease exposure, depending on the
type ofpollution in the air and ventilation
available in the building (21). Although
eliminating a precipitant such as Alternaria
at its source may be virtually impossible, for
others (e.g., smoke, particulates), prevention
through regulatory means maybe possible.
Two points seem evident regarding
environmental precipitants ofasthma. First,
additional research is needed to identify the
independent and combined, direct and indi-
rect effects ofindoor and outdoor air quality
factors on the disease. Second, the effective-
ness ofvarious environmental control inter-
ventions to reduce asthma prevalence and
symptom exacerbations must be tested.
Precipitants in thesocialenvironment
includingpsychosocialfactors. As with
most diseases, it appears that stress can
make asthma control more difficult. The
extent to which it is a direct precipitant of
wheezing and other asthma symptoms has
not been noted. However, clinical recom-
mendations and asthma self-management
programs routinely counsel families to help
children reduce their levels ofstress both
generally and during symptom exacerba-
tions. Although little research has explored
the idea, researchers have hypothesized that
social environmental stresses of urban
inner-city living, such as lack ofsupportive
relationships, lack ofcommunity resources,
violence, and economic worries are psy-
chosocial risk factors for greater asthma-
related problems among children living in
these communities (57-59). Increased
crime, noise pollution, and lack of safe
transportation also have been suggested as
aspects ofthe inner city that have a deleteri-
ous effect on day-to-day life. Such risk fac-
tors may operate directly on a child's health
or, by increasing family stress, can indi-
rectly affect efforts to manage the child's
asthma (59,60).
Environmental Health Perspectives * Vol 107, Supplement 3 * June 1999 423CLARK ETAL.
Community-Wide Control
Comprehensive Efforts Are Needed
For asthma, a ubiquitous disease for which
there is no cure and no clear cut preventive
or therapeutic answer, a comprehensive
approach to control is needed that involves
all the parties directly or indirectly affected
by the disease. Once the right medical regi-
men for aparticular child is prescribed, 90%
ofday-to-day dinical control ofasthma is in
the hands of patients and their parents.
However, the family obviously cannot exert
control over all the factors that can exacer-
bate the disease and needs assistance in a
variety of ways. Until underlying causes are
known and prevented, the patient's efforts
to self-manage must be at the center of con-
certed activities at multiple levels of
endeavor in order to control the disease.
Figure 1 offers a picture ofthe concentric
circles ofinfluence and relationship that are
necessary for asthma control. This perspec-
tive is consistent with a social-ecologic
framework that recognizes that individuals
are embedded within psychosocial, social,
political, and economic systems that shape
behaviors and health status (61). This
approach suggests that interventions aimed
at changing an individual's behavior must
consider social relationships and resulting
influences (such as family, clinicians,
school personnel, classmates, neighbors) as
well as the physical influences (e.g., loca-
tion ofhousehold near high levels ofambi-
ent air pollution) in the individual's life.
Additionally, interventions must consider
how individuals modify their surroundings
through individual and collective actions
aimed at changing influences in the multiple
rings ofthe concentric circles.
Figure 1. Concentric circles of influence in asthma
control.
PatientandFamilySelf-Management
Self-management in asthma has been
carefully distinguished in practice and
research from self-treatment. In such a
complex chronic disease, a partnership
between patient and clinician is necessary
to establish and maintain over time the
correct therapeutic regimen for control.
Self-management in asthma refers to the
activities that the patient and family under-
take on their own with guidance and
instruction from the clinician.
A number ofstudies over the past 15
years (62,63) have demonstrated the
importance ofasthma self-management to
disease control when control is defined as
fewer symptom episodes and less health ser-
vice use. Several of these studies involve
programs in which the child, the parent, or
both are trained to undertake measures to
reduce and handle the onset ofsymptoms.
The self-management programs have
focused on managing asthma symptoms,
preventing attacks, and developing commu-
nication among family members and
between family and clinician. These inter-
ventions often include environmental con-
trol and special efforts to remove or avoid
suspected irritants (e.g., tobacco smoke)
and allergens (i.e., reduce exposure to dust
mites and cockroaches, and avoid animal
dander) ifthese give rise to symptoms.
Evaluation designs have precluded
determination ofwhich educational ele-
ments (use of medicine, environmental
control, enhanced management ofsymp-
toms, etc.) are responsible for observed out-
comes. However, these comprehensive
programs to improve self-management have
been highly successful in reducing episodes
of symptoms, improving school perfor-
mance, enhancing psychological well-being,
and decreasing hospital and emergency
department use. Table 1 (64-81) provides
a summary of these asthma intervention
studies and evaluation results.
RoleoftheClinician
It is estimated that 80-90% of children
with asthma see general practice physicians
for their care and an additional 10-20%
are seen by pulmonologists or allergists. A
range ofother clinicians (e.g., nurses, res-
piratory therapists) see patients who use
hospital and clinical services. However,
these estimates do not account for the fact
that large numbers ofchildren, primarily
in low income, racial/ethnic minority
communities, do not receive regular care
for the disease.
Efforts to reach clinicians have been
undertaken by professional associations and
the NAEPP, but it is accepted that the rec-
ommendations in the "Guidelines for
Diagnosis and Treatment ofAsthma" (10)
are not followed in an optimum way by
health professionals (82). Enhancing clini-
cal practice is essential to control. Although
there are very few rigorously evaluated pro-
grams for changing clinician behavior in
asthma where outcomes for children have
been assessed, two studies are worth noting.
Both have been based on the idea that the
clinician must not only understand effective
therapeutic regimens for asthma but also
must be able to communicate about the
disease in such a way that patient self-
management, including efforts to control
factors in the physical environment, is opti-
mized. These studies have demonstrated
positive results regarding improved clini-
cian prescribing and counseling practices
(35,83). One study (83) has shown reduc-
tions in health care use when patients see
physicians trained to treat and communicate
in the recommended way.
InfluenceoftheSocialandPhysical
EnvironmentoftheSchool
Literature over theyears has shown a general
lack of understanding ofasthma treatment
by school personnel and classmates of
children with asthma (84). How to treat
emergencies and how to support self-
management of children with the disease
are unresolved issues in many schools. In
communities where there are no school
physicians or nurses, providing adequate
self-management support is almost always a
concern. At least two studies (35,85) have
shown that providing asthma self-manage-
ment education to children during school
time can significantly reduce the child's
symptoms, improve psychological adjust-
ment, and enhance school performance.
However, the independent effect of
increasing the information and skills of
principals, teachers, and classmates on the
child's ability to manage asthma has not
been evaluated.
Further, to date no rigorous study has
been undertaken to assess the impact of
modifications in the school's physical envi-
ronment on the health of children with
asthma. It is believed that the physical envi-
ronment ofthe school may pose a threat to
the health ofthese children. For example,
high levels ofhumidity may contribute to
dust mite proliferation; air intakes maybring
in gases, fumes, or odors; strong chemicals
may be used for deaning; cockroach antigen
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Table 1. Outcomes of evaluated pediatric asthma education.
Evaluation Follow-up
Study n design period Outcomes
Staudenmayer etal. (64)
Fireman et al. (65)
Clark et al. (66)
Lewis etal. (67)
Hindi-Alexander and Cropp(68)
McNabb etal. (69)
Rubin etal. (70)
LeBaron et al. (71)
Wilson and Starr-Schneidkraut (72)
Mesters etal. (73)
Rakos et al. (74)
Mitchell etal. (75)
Mcintosh etal. (76)
Jenkinson etal. (77)
Parcel etal. (78)
Evans et al. (79)
Hughes etal. (80)
Robinson (81)
40 Pre/post 6 months Change in direction offewer school absences(p=0.09)
Reduced number ofemergency physician visits forthose with baseline use(p= 0.03)
Reduced hospitalizations (p=0.03)
26 RCT 6-16 months Decreased school absences(p< 0.05)
Reduced ED use (no statistical analysis)
Reduced hospitalization time (no statistical analysis)
310 RCT 1 year Improved academic performance(p=0.05)
Increased self-management behavior: parent(p= 0.0001); child (p=0.05)
No difference in school absences
Reduced ED use among those with baseline use (p=0.05)
Reduced hospitalizations among those with baseline use (p= 0.05)
76 RCT 1 year Reduced ED visits (p< 0.001)
Reduced number of hospital days (p<0.01)
92 Pre/post 1 year Reduced school absences (p<0.005)
Reduced ED use but notstatistically significant
No difference in hospitalizations
14 Pre/post 1 year Reduced ED use (no statistical analysis)
54 RCT 1 year No difference in school absences
Improvement in ED use but not statistically significant
31 RCT 4 months Increased knowledge about cromolyn (no statistical analysis)
No change in pulmonaryfunction or systems
80 RCT 1 year Increased symptom free days(p=0.004)
Fewer nights of parental sleep interruption
67 RCT 1 year Higher level of asthma self-efficacy (p<0.02)
Increased self-management behavior(p< 0.01)
Decreased physician visits (p< 0.01)
43 RCT 1 year No significant difference in school absences
No significant differences in ED use or emergency physician visits
368 RCT 6 months Differences according to ethnicity ofchildo no differences in hospital days
92 RCT 4-6 months More treatment(35%)than control (17%)subjects reported smoking outside their
homes at posttest(and theirchildren's continine levels were lower) but not
statistically significant
177 RCT 3 and Significant knowledge increases (p= 0.002)
12 months No other significant change
104 Comparison 1 year Improved ED use but not significantly significant
group Higher levels ofself-efficacy regarding asthma (p=0.018)
239 RCT 1 year Increased self-management (p=0.05)
Increased communication with parent(p=0.002)
Better academic grades (p=0.05)
Fewer days with symptoms (p=0.004)
95 RCT 1 year Reduced school absences (p=0.04)
74 Pre/post 3 years Reduced school absences (no statistical analysis)
Better MDI technique (0.0005)
Fewer hospital days(0.02)
Abbreviations: ED, emergency department; MDI, meterdose inhaler; pre, before intervention test; post, after intervention test; RCT, random controlled trial.
or animal dander may be present; chalkdust
may be prevalent; and offending pesticides
maybeemployed.
CommunityAwareness, Support,
andAction
Some surveys and extensive clinical
experience have led to the conclusion that
many asthma patients do not know the
benchmarks ofsuccessful asthma treatment
and therefore live with a lower level of
functioning than should be accepted. As a
result, a number of national organizations
have produced educational materials
designed to help patients and the public
recognize the goals ofcare, i.e., the child
with asthma should be able to sleep
through the night, participate in normal
physical activity without exacerbations and
be symptom free. Public understanding of
the extent ofasthma prevalence, the objec-
tives of treatment, and the ways to foster
self-management so that patients receive
adequate support for their management
efforts is seen as an important route to
asthma control.
For children with asthma, control
requires knowledge ofthe principles ofself-
management as well as support from fam-
ily, friends, and neighbors with whom the
children, their parents, and caregivers
interact on a regular basis. Community-
level interventions can help to provide that
support in different ways. In one study
focusing on improving clinical care (86), a
community-wide campaign was success-
fully employed to achieve better coordina-
tion of asthma clinical services. Another
study focusing on asthma among residents
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oflow-income neighborhoods in St. Louis,
Missouri (87), showed that mobilizing
community residents and organizations on
behalf of asthma control had positive
effects. This project undertook an informa-
tion campaign and also trained community
residents to counsel patients with asthma
and refer them for service. Introduction of
the neighborhood workers significantly
increased the number of asthma patients
who were informed about their disease and
sought appropriate care.
Currently, there are more than 45 active
community coalitions in the United States
for asthma control. These coalitions are pri-
marily partnerships ofpatient, provider, and
community organizations in the public, pri-
vate, and voluntary sectors seeking to coor-
dinate their efforts and to increase public
awareness ofasthmacontrol activities (88).
An intervention that has not yet been
explored is use ofa community organizing
approach to reduce psychosocial stressors at
the neighborhood level. Given the previ-
ously mentioned hypothesized relationship
between stressors in the urban inner-city
environment and the increase in asthma in
urban areas, a neighborhood intervention
that targets more general psychosocial stres-
sors such as crime, violence, noise pollution,
and lack ofcommunity resources may help
in asthma control.
Communty-Wde Control of
Environmental Influences
Although patients sensitive to indoor
environmental precipitants can do much to
reduce some ofthese triggers to symptoms
(e.g., dust mites, cockroach, dander,
tobacco smoke), not all remedies are within
their total control. Neighborhood or com-
munity-wide strategies may be required.
Further, the quality ofoutdoor air is cer-
tainly beyond the control ofan individual
family. Some effective remedies for air pol-
lution may be accomplished by legal or reg-
ulatory intervention. To effect macro-level
control measures, a combination of com-
munity organization and policy change
strategies will be needed. Most important,
interventions designed to reach across com-
munities and even nations must be based
on sound scientific evidence. More research
is needed to fill thewide gaps in our current
knowledge ofenvironmental influences.
TheRoleofPublicand
IntiutionalPolicy
The final ring of the concentric circles
shown in Figure 1 represents policies
conducive to asthma control. In certain
areas ofpolicy the answers seem clear-cut.
For example, in some American states chil-
dren are not allowed to carry their asthma
medicines with them at school. In other
parts ofthe United States, explicit policies
ofthe state department ofeducation and/or
health ensure children access to these medi-
cines during the school day, and this is a
trend to be encouraged. Yet another exam-
ple is the availability of school nurses in
some school districts to see children with
asthma. Again, this is a policy that may
assist families to manage asthma better.
But other areas are less clear. Can and
should certain standards ofenvironmental
control (e.g., cleanliness ofschool facilities,
levels of acceptable exposure to diesel
exhaust particulate, levels ofacceptability for
building construction) be tied to expected
improvements in asthma? What types of
policy changes are appropriate and effective?
Considerable research is needed to address
these questions. Further, it is accepted that
access to sufficient clinical care is central to
asthma control. Increased morbidity and
mortality, especially in low-income families,
has been tied to inadequate medical care
(89). National, state, and community-wide
policies for ensuring availability ofappropri-
ate and effective treatment, including rea-
sonable access to general and specialized
services, is fundamental to control.
Projects ofthe Michigan
Centerforthe Environment
and Children's Heafth
Based on the research evidence and concep-
tual framework described above, in an
effort to control asthma in school-age chil-
dren in low-income neighborhoods of
Detroit, Michigan, the Michigan Center
for the Environment and Children's Health
(MCECH) has mounted three studies.
MCECH is a collaborative research initia-
tive funded by the U.S. Environmental
Protection Agency and the National
Institute ofEnvironmental Health Sciences
and based at the University of Michigan
School ofPublic Health. An important fea-
ture of MCECH is the local partnership
between university researchers, health agen-
cies, and community-based organizations in
which all three constituent bodies jointly
decide the research questions, design, and
methods for the center's projects. The cen-
ter is an outgrowth ofthe work ofan ongo-
ing community health agency-University
of Michigan partnership, the Detroit
Community-Academic Urban Research
Center, funded in 1995 by the Centers for
Disease Control and Prevention (90,91).
The work ofMCECH is guided by a set of
community-based research principles (91)
that specify a participatory, collaborative
approach to research. All parties are actively
involved in the research process aimed at
integrating knowledge and action for
mutual benefit of all partners (92). By
using this partnership approach, MCECH's
efforts are consistent with the call among
health researchers for greater community
involvement in research and interventions
(60,93,94) in order to better identify and
address the complex issues that compro-
mise the health ofpeople living in margin-
alized communities (95-97). The overall
goals of the three core MCECH research
projects are to identify features of the
underlying inflammation associated with
asthma, to monitor the effects ofair quality
on asthma exacerbations, and to build the
capacity of children and their families to
reduce precipitants of symptoms. The
studies (briefly described below) are orga-
nized to attend to the associations and rela-
tionships ofinfluence depicted in Figure 1.
They are guided by steering committees
composed of representatives from the
partner organizations involved.
ThePathogenesis ofAsthma
Although studies have confirmed that
asthma symptoms are precipitated by expo-
sure to cockroach allergen, mediators within
the lung that dictate the progression ofdis-
ease have not yet been fully defined.
Targeted pharmacologic therapy has the
potential to improve the treatment of
asthma by addressing those mediators
directly responsible for exacerbations. This
MCECH project is testing the hypothesis
that asthmalike pulmonary injury is medi-
ated by the local production ofchemokines.
Chemokines are small molecular weight
peptides that induce the chemotaxis and
recruitment ofinflammatory cells. They are
powerful mediators with long-lasting and
potent biologic activities. This study exam-
ines the acute and chronic pulmonary
inflammation that develops after direct
injection ofthe chemokines into the lung.
The assessment ofthe injury includes histo-
logic and morphometric analysis as well as
an assessment ofthe innervation ofthe air-
ways. The project also involves the develop-
ment of a mouse model of asthmalike
pulmonary inflammation in response to
cockroach allergen. This model was devel-
oped by locating households with high lev-
els of cockroach allergen and using this
material to immunize the mice. The mice
are challenged by exposure to aerosols
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containing the allergen-bearing dust and the
pulmonary injury is carefully quantified. An
important related activity is investigation of
the biochemical pathways responsible for
the upregulation ofchemokines in cells sen-
sitized and then challenged with cockroach
allergen. Reactive oxygen and reactive
nitrogen intermediates are of particular
interest, as they increase the transcription of
chemokines. Finally, the project is testing
the central hypothesis that chemokines are
important in the pathogenesis ofasthma.
This test entails blocking the biologic activ-
ity ofthe chemokines with specific neutral-
izing antibodies and determining ifthere is
a reduction in the pulmonary inflammation
induced by repeated exposures to cockroach
allergen. Successful completion of the
project will help to both delineate the
underlying inflammatory mechanisms of
disease and identify potential novel targets
for intervention.
Exposure toIndoorandOutdoorAir
National trends in the increase in asthma
are especially visible in inner-city Detroit.
This research is contributing to the identifi-
cation ofcombinations offactors that pre-
cipitate asthma symptoms. First, the
prevalence ofasthma among the elementary
school-age children in two distinct racial/
ethnic minority urban populations (African
American, Hispanic) in Detroit is being
determined. Approximately 7,000 students
attending elementary schools in the two
areas of Detroit where MCECH commu-
nity partner organizations are located are
invited to participate in the first phase ofthe
research. The child's parent completes a
short screening questionnaire for asthma,
and those with diagnosed and suspected
asthma are enrolled in the second phase of
the study. Through home visits and moni-
toring, the presence ofcomponents ofthe
ambient air and ofindoor air contaminants
is determined. Family and neighborhood
characteristics (e.g., stressors) associated
with increased risk for asthma are also iden-
tified. Subsequently, data regarding seasonal
and daily fluctuations in ambient air pollu-
tion and indoor air contaminants are ana-
lyzed for their association with changes in
children's asthma symptoms. In addition,
relationships between exposures to environ-
mental factors and physical activity patterns
of children with asthma are assessed.
Findings from this project will enhance
understanding ofthe effects of individual
and combined environmental precipitants
on asthma exacerbations and on activity
limitations ofchildren.
ACommunity-BasedIntervention to
ReduceEnvironmental Precipitants
This project is seeking an effective way to
reduce exposure of children to negative
environmental factors at home and within
their neighborhoods. The homes of chil-
dren with asthma who are enrolled in the
study described above are beingvisited over
a 2-year period (nine visits in the intensive
first year, three visits in the second year) by
trained community environmental special-
ists. These outreach workers work with the
family to share information on asthma self-
management and environmental triggers
and to reduce indoor environmental factors
such as cockroach allergen, cat dander, and
environmental tobacco smoke. In the sec-
ond year ofthe intervention project, this
household intervention is combined with a
neighborhood-level intervention designed
to mobilize community residents and orga-
nizations to support families in their efforts
to exert environmental control and reduce
neighborhood-level psychosocial stressors.
Combinations of these two interventions
ofvarying lengths oftime and intensity are
being tested in conjunction with the data
collected in the exposure study. When
completed, the study will shed light on the
effectiveness ofhousehold and community-
level interventions in changing family and
community environmental control behav-
ior and the symptom status of children
with asthma.
To mount effective and comprehensive
approaches to control and to identify means
to prevent childhood asthma, significant
additional environmentally focused com-
munity-based research will be needed ofthe
types being undertaken by MCECH and
other centers around the country. The con-
centric circles of association necessary for
asthma control presented here (Figure 1),
provide a useful framework for conducting
this research.
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